Wells Fargo’s MIRA Pharmaceuticals MIRA Stock Holding History

Wells Fargo’s Portfolio MIRA Stock Details MIRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-23	Closed	-$25	–	7486
2026 Q1	$25	Hold	23	–	–	﹤0.01%	6749
2025 Q4	$35	Hold	23	–	–	﹤0.01%	6606
2025 Q3	$31	Buy	+23	New	+$33	﹤0.01%	6596

Other funds holding MIRA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CSI

Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

FAB

First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wells Fargo's MIRA Position: Q2 2026 in Review

Wells Fargo sold out of MIRA Pharmaceuticals (MIRA) in Q2 2026, closing a stake of 23 shares — an estimated $25 sold.

Wells Fargo first reported a position in MIRA in Q3 2025 and held it in 3 quarters. The position peaked at $35 in Q4 2025. 26 funds tracked by Wall St. Rank hold MIRA as of Q2 2026.

Wells Fargo reported no remaining MIRA Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Wells Fargo sold 23 MIRA Pharmaceuticals shares in Q2 2026, an estimated $25.
Wells Fargo first reported a position in MIRA Pharmaceuticals in Q3 2025 and held it in 3 quarters.
Wells Fargo's MIRA Pharmaceuticals position peaked at $35 in Q4 2025.
26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.